News

Counterfeit and substandard drugs in India may be smaller problem than claimed, say government findings

BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g60 (Published 07 January 2014) Cite this as: BMJ 2014;348:g60
  1. Cheryl Travasso
  1. 1Mumbai

Only a very small fraction (0.05%) of drugs made in India and tested by the Central Drugs Standard Control Organisation between 2009 and 2012 were “spurious” (counterfeit) or substandard, government data have shown.

In 2009 the drugs agency published its Report on Countrywide Survey for Spurious Drugs concerning what it believed were mostly unverified and sensational reports that between 10% and 25% of Indian drugs were “spurious.”1 Spurious drugs are defined as those that are manufactured under another drug name or that wrongly claim to be …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe